Safety of transrectal ultrasound-guided prostate biopsy in patients affected by Crohn’s disease

  • Lucio Dell'Atti | dellatti@hotmail.com Department of Urology, University Hospital “Ospedali Riuniti”, Ancona, Italy.
  • Andrea Benedetto Galosi Department of Urology, University Hospital “Ospedali Riuniti”, Ancona, Italy.

Abstract

Purpose: Crohn’s disease (CD) is a chronic inflammatory condition of the gastrointestinal tract. It is usually considered a contraindication to transrectal ultrasound-guided prostate biopsy (TRUSBx). The aim of this study was to investigate the safety of TRUSBx in a small cohort of patients with CD. Methods: We queried our institutional database clinical data of patients with a diagnosis of CD undergoing TRUSBx, and a retrospective prospective study of 5 patients was planned. All patients enrolled were in the remission phase of CD and asymptomatic. They received the same antibiotic prophylaxis and a povidone-iodine aqueous solution enema before the procedure. A standardized reproducible technique was used with using a ultrasound machine equipped with a 5-9 MHz multifrequency convex probe “end-fire”. The patients were treated under local anaesthesia, and a 14-core biopsy scheme was performed in each patient as first intention. After the procedure each patient was given a verbal numeric pain scale to evaluate tolerability of TRUSBx. Results: TRUSBx was successfully completed in all patients. The number of biopsy cores was 14 (12-16). Of the 5 biopsy procedures performed 40% revealed prostatic carcinoma (PCa) with a Gleason score 6 (3+3). No patients required catheterization or admission to the hospital for adverse events after the procedure. The most frequent adverse event was hematospermia (60%), while hematuria was present in 20% of patients and a minimal rectal bleeding in 20% of the patients. No patients reported severe or unbearable pain (score ≥ 8). Conclusions: This study suggests that CD may not be an absolute contraindication to TRUSBx for prostate cancer detection, but still requires a careful patients selection.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Author Biography

Lucio Dell'Atti, Department of Urology, University Hospital “Ospedali Riuniti”, Ancona
Department of Urology
Published
2017-06-30
Info
Issue
Section
Original Papers - Prostate
Supporting Agencies
none
Keywords:
Crohn’s disease, Inflammatory bowel disease, Prostate biopsy, Ultrasonography, Prostate cancer, Complications.
Statistics
  • Abstract views: 1150

  • PDF: 592
How to Cite
Dell’Atti, L., & Galosi, A. (2017). Safety of transrectal ultrasound-guided prostate biopsy in patients affected by Crohn’s disease. Archivio Italiano Di Urologia E Andrologia, 89(2), 106-109. https://doi.org/10.4081/aiua.2017.2.106